Role of the CX3C chemokine receptor CX3CR1 in the pathogenesis of atherosclerosis after aortic transplantation

Regulation of atherosclerotic plaque inflammation

(2015) M. Bäck et al.   JOURNAL OF INTERNAL MEDICINE

Coronary Injury Score Correlates with Proliferating Cells and Alpha-Smooth Muscle Actin Expression in Stented Porcine Coronary Arteries

(2015) Vicki J. Swier et al.   PLoS One

Chemokines and atherosclerosis: focus on the CX3CL1/CX3CR1 pathway

(2013) Stavros Apostolakis et al.   ACTA PHARMACOLOGICA SINICA

Pharmacological Inhibition of the Chemokine Receptor, CX3CR1, Reduces Atherosclerosis in Mice

(2013) Lucie Poupel et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Contribution of Platelet CX 3 CR1 to Platelet–Monocyte Complex Formation and Vascular Recruitment During Hyperlipidemia

(2012) Otilia Postea et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Cross talk between smooth muscle cells and monocytes/activated monocytes via CX3CL1/CX3CR1 axis augments expression of pro-atherogenic molecules

(2011) Elena Dragomir Butoi et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Non- invasive in vivo analysis of a murine aortic graft using high resolution ultrasound microimaging

(2011) Zuzanna Rowinska et al.   EUROPEAN JOURNAL OF RADIOLOGY

Impact of chemokine receptor CX3CR1 in human renal allograft rejection

(2010) Ute Hoffmann et al.   TRANSPLANT IMMUNOLOGY

Aspirin Inhibits Fractalkine Expression in Atherosclerotic Plaques and Reduces Atherosclerosis in ApoE Gene Knockout Mice

(2009) Hong Liu et al.   CARDIOVASCULAR DRUGS AND THERAPY

Fractalkine has anti-apoptotic and proliferative effects on human vascular smooth muscle cells via epidermal growth factor receptor signalling

(2009) Gemma E. White et al.   CARDIOVASCULAR RESEARCH

Chemokines in Atherosclerosis

(2008) Alma Zernecke et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival

(2008) L. Landsman et al.   BLOOD

Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6C hi and Ly6C lo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice

(2008) Christophe Combadière et al.   CIRCULATION

CX 3 CR1 Deficiency Impairs Dendritic Cell Accumulation in Arterial Intima and Reduces Atherosclerotic Burden

(2007) Peng Liu et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Fractalkine Deficiency Markedly Reduces Macrophage Accumulation and Atherosclerotic Lesion Formation in CCR2 −/− Mice

(2007) Noah Saederup et al.   CIRCULATION